Association between patient-reported eating behaviours and weight change: Secondary analyses of a randomized, double-blind trial comparing retatrutide and placebo in people with obesity or overweight
- PMID: 40735804
- PMCID: PMC12409224
- DOI: 10.1111/dom.16662
Association between patient-reported eating behaviours and weight change: Secondary analyses of a randomized, double-blind trial comparing retatrutide and placebo in people with obesity or overweight
Keywords: anti‐obesity drug; appetite control; patient‐reported outcomes; weight management.
Conflict of interest statement
Chisom Kanu, Qiwei Wu, Jiat Ling Poon, Iris Goetz, Magaly Perez‐Nieves, Kristina Boye, Tamer Coskun, and Mark L. Hartman are employees and stockholders of Lilly. Corby K. Martin has been the primary investigator and co‐investigator on research contracts from Lilly, which were paid to his institution. His institution has also received funds via contracts with Lilly to provide advice on patient‐reported outcomes when designing studies. These agreements were not related to the current work. Lilly manufactures the drug studied in this paper.
Figures

References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources